Brigitte C. Widemann

15.9k citations

249 papers · 7.9k indexed · 1 hit paper · h-index 51

Impact in

Neurology top 0.1%
- Neurofibromatosis and Schwannoma Cases
- Neuroblastoma Research and Treatments
- Vascular Malformations Diagnosis and Treatment
Pathology and Forensic Medicine top 0.5%

Papers in

Neurology 149
- Neurofibromatosis and Schwannoma Cases 116
- Neuroblastoma Research and Treatments 71
Genetics 38
- Glioma Diagnosis and Treatment 32

Co-authors: Peter C. Adamson Eva Dombi Frank M. Balis Elizabeth Fox AeRang Kim Seth M. Steinberg Pamela L. Wolters Andrea Baldwin
Journals: Journal of Clinical Oncology (45 papers)Pediatric Blood & Cancer (18 papers)Clinical Cancer Research (15 papers)Neuro-Oncology (14 papers)Neurology (12 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Brigitte C. Widemann

239 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

Understanding and Managing Methotrexate Nephrotoxicity 2006 · 533 citations

Peers

Countries citing papers authored by Brigitte C. Widemann

Since Specialization

Citations

This map shows the geographic impact of Brigitte C. Widemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte C. Widemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte C. Widemann more than expected).

Fields of papers citing papers by Brigitte C. Widemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte C. Widemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte C. Widemann. The network helps show where Brigitte C. Widemann may publish in the future.

Co-authors

The 25 scholars most cited alongside Brigitte C. Widemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brigitte C. Widemann Line = papers co-authored together Brigitte C. Widemann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm Neuro-Oncology Advances ·Ayoade Adeyemi, Andrea M. Gross, Andrea Baldwin, Eva Dombi, Brigitte C. Widemann, Kyaw Sint	2025	0
2	Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib JAMA Dermatology ·Andrea M. Gross, 久幸須藤, Lauren Baldwin, Ashley Cannon, Hyoyoung Choo‐Wosoba, Seth M. Steinberg, Shaohuai Chen, Pamela L. Wolters, Dominique C. Pichard, Cecilia Tibery, Eva Dombi, Joanne Derdak, Brigitte C. Widemann, Bruce R. Korf	2025	1
3	SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES). Journal of Clinical Oncology ·Patrick J. Grohar, Karla V. Ballman, Zifan Song, Leo Mascarenhas, John Glod, Hidehisa Suzumura, Windi Habsari, Steven G. DuBois, Robert G. Maki, Brian D. Crompton, William D. Figg, Rochelle Bagatell, Theodore W. Laetsch, Mark S. Diamond, Fariba Navid, Ryan D. Roberts, Brigitte C. Widemann, Denise K. Reinke, Rashmi Chugh	2024	5
4	Parent–child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1. Journal of Family Psychology ·Ae Lee Im, Tarig Salah, Staci Martin, Євген Попов, Brigitte C. Widemann, Pamela L. Wolters	2024	0
5	Monitoring change in heart rate variability following acceptance and commitment therapy for chronic pain: Results of a randomized controlled trial for individuals with neurofibromatosis type 1 Journal of Contextual Behavioral Science ·Taryn Allen, Kari Struemph, Mary Anne Toledo‐Tamula, Jiajun Zhang, Liangbin Shao, Pamela L. Wolters, Andrea Baldwin, Brigitte C. Widemann, Staci Martin	2023	1
6	Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials Clinical Trials ·Ashley Cannon, Kavita Y. Sarin, Andrea Petersen, Dominique C. Pichard, Pamela L. Wolters, Е А Кутырев, Sounantha Boutxakittilath, Peng Li, Claas Röhl, Tena Rosser, Brigitte C. Widemann, Jaishri O. Blakeley, Scott R. Plotkin	2023	0
7	Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas Neuro-Oncology ·Andrea M. Gross, Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Molka Osman, Tiffany Thomas, Staci Martin, Joanne Derdak, Kara Heisey, William E. Watson, Seth M. Steinberg, David Venzon, Michael J. Fisher, AeRang Kim, Miriam Bornhorst, Brian Weiss, Jaishri O. Blakeley, Malcolm A. Smith, Brigitte C. Widemann	2023	44
8	Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1 The Journal of Pediatrics ·Chelsea Kotch, Eva Dombi, Amish C. Shah, Ayasa Kamezaki, Symone M. Brown, Yimei Li, Brigitte C. Widemann, Michael J. Fisher	2023	2
9	Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies Molecular Cancer Therapeutics ·K. Kanda, Casey L. Kilpatrick, Melinda G. Hollingshead, Dominic Esposito, Geraldine O’Sullivan Coyne, Andrea M. Gross, Barry C. Johnson, Alice P. Chen, Brigitte C. Widemann, James H. Doroshow, Ralph E. Parchment, Apurva K. Srivastava	2021	3
10	Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma Current Oncology ·K. Cenzual, J. Kyle Upchurch, David Venzon, David J. Liewehr, Tiarma Nova Intan Malasari, M. Harikrishna M.V.L.R. Anjaneyulu M.J. Neena, Maureen Edgerly, Victoria Anderson, Elliot Levy, Raquel Pontet, Elizabeth C. Jones, Karlyne M. Reilly, Brigitte C. Widemann, Bradford J. Wood, Hadi Bagheri, Jaydira Del Rivero	2021	2
11	Chordoma: Current status, problems, and future directions Current Problems in Cancer ·Mary Frances Wedekind, Brigitte C. Widemann, Gregory M. Coté	2021	30
12	Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas Clinical Cancer Research ·Nurainun Adamy, John Glod, 小西健介, Miki Kasai, Joanne Derdak, Eva Dombi, Alphonse Kwawisi Tekpetey, Daniel W. Beury, Melinda S. Merchant, Heejae So, David J. Liewehr, Seth M. Steinberg, Brigitte C. Widemann, Rosandra N. Kaplan	2020	21
13	Genome‐wide association study of café‐au‐lait macule number in neurofibromatosis type 1 Molecular Genetics & Genomic Medicine ·Heejong Sung, Paula L. Hyland, Alexander Pemov, 李渔, Andrea Baldwin, Sara Bass, О. В. Пучка, Wen Luo, Brigitte C. Widemann, Douglas R. Stewart, Alexander F. Wilson	2020	4
14	Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib Clinical Cancer Research ·Ira L. Kraft, Srivandana Akshintala, David Ronald, Haiyan Lei, J. Senff, Eva Dombi, Seth M. Steinberg, Maya Lodish, Steven G. Waguespack, Oxana B. Kapustina, Elizabeth Fox, Frank M. Balis, Maria J. Merino, Paul S. Meltzer, John Glod, Jack F. Shern, Brigitte C. Widemann	2017	20
15	Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer Clinical Cancer Research ·Jung Min Lee, Cody J. Peer, Minshu Yu, Lauren Amable, Nicolas Gordon, Christina M. Annunziata, Nicole Houston, Andrew K.L. Goey, Tristan M. Sissung, QilongLi, Lori M. Minasian, Victoria L. Chiou, Robert F. Murphy, Brigitte C. Widemann, William D. Figg, Elise C. Kohn	2016	47
16	Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas Journal of Clinical Oncology ·Jaishri O. Blakeley, Xiaobu Ye, Dan G. Duda, Chris Halpin, Amanda L. Bergner, Alona Muzikansky, Vanessa L. Merker, Elizabeth R. Gerstner, Laura M. Fayad, Shivani Ahlawat, Michael A. Jacobs, Rakesh K. Jain, Christopher Zalewski, Eva Dombi, Brigitte C. Widemann, Scott R. Plotkin	2016	86
17	Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma Clinical Cancer Research ·Elizabeth Fox, Brigitte C. Widemann, Meredith K. Chuk, Leigh Marcus, Alberta Aikin, Patricia Whitcomb, Maria J. Merino, Maya Lodish, Eva Dombi, Seth M. Steinberg, Samuel A. Wells, Frank M. Balis	2013	110
18	A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report Clinical Cancer Research ·Brigitte C. Widemann, AeRang Kim, Elizabeth Fox, Sylvain Baruchel, Peter C. Adamson, Ashish M. Ingle, Julia Glade Bender, Michael Burke, Brenda J. Weigel, Diana Stempak, Frank M. Balis, Susan M. Blaney	2012	90
19	Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1 Neuro-Oncology ·Naufal Kurniawan, Lym Cs, Eva Dombi, C. Fünsterer, Lan Kluwe, Yuqi Dai, Brigitte C. Widemann, Jan M. Friedman	2008	177
20	High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease The Journal of Pediatrics ·R. N. Weigle, Ihsan Yalcin, Peter Lasch, Людмила Анатольевна Пынченкова, J. U. Leititis, С.А. Никитин, Robert L. Esken, А. Н. Хатькова, Claudia Roll, Bernd Roth, H. B. von Stockhausen, Brigitte C. Widemann, V. Wahn	1992	84

About Brigitte C. Widemann

Brigitte C. Widemann is a scholar working on Neurology, Genetics, Hematology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 249 papers that have together received 7.9k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (116 papers), Neuroblastoma Research and Treatments (71 papers), Sarcoma Diagnosis and Treatment (55 papers), Meningioma and schwannoma management (44 papers), Glioma Diagnosis and Treatment (32 papers), Acute Lymphoblastic Leukemia research (19 papers), Soft tissue tumors and treatment (17 papers) and Neuroendocrine Tumor Research Advances (17 papers). The work is most often cited by research in Neurology (3.6k citations), Pathology and Forensic Medicine (1.3k citations), Genetics (756 citations), Pulmonary and Respiratory Medicine (2.1k citations) and Hematology (695 citations). Brigitte C. Widemann has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Peter C. Adamson, Eva Dombi, Frank M. Balis, Elizabeth Fox, AeRang Kim, Seth M. Steinberg, Pamela L. Wolters, Andrea Baldwin, Nalini Jayaprakash and Andrea Gillespie. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Clinical Cancer Research, Neuro-Oncology and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact